News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mersana Therapeutics, Inc. Appoints Donald A. Bergstrom, M.D., Ph.D., And Eva M. Jack To Executive Leadership Positions


1/8/2014 8:42:15 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Mersana Therapeutics, a biopharmaceutical company developing its Fleximer® antibody-drug conjugate (ADC) platform and therapeutics, today announced two executive appointments. Donald A. Bergstrom, M.D., Ph.D., has been appointed Chief Medical Officer, adding substantial experience in oncology translational research to Mersana's team. Eva M. Jack has been appointed Mersana's Chief Business Officer, bringing a successful track record in business development and venture capital.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES